KEY PONTIFICATION: The all front attack against pharma drug pricing is going to de very little to lower overall healthcare costs but politicians are not about providing REAL results, they…
Category: Business of the drug industry
Earning the trust of patients
Edelman’s annual trust barometer research recorded an increase of 6 points in the U.S. that helped pharma reach a new rating score of 44. The industry would need to reach 50…
Some healthcare facts we all should know
In a partisan political climate, leaders on both sides of the aisle have identified an urgent challenge: the price of prescription drugs. The average American pays approximately $1,200 a year for prescriptions – and that…
Most people said they trust drug companies to come up with new and effective drugs
Most people — 71% — said they trust drug companies to come up with new and effective drugs. But 80% said industry profits are a major factor in high drug…
Why is pharma so addicted to growth?
As sales of Merck & Co.’s immuno-oncology heavy hitter Keytruda soared 66% in the fourth quarter to $2.15 billion, surpassing Wall Street’s expectations they were knocked because analysts want to…
Pharma still blaming drug middlemen for obscene prices
Pharma, which used to cite the high cost of research, now say rebates within supply chain drive up prices. Pharma says they don’t actually benefit much from list-price increases and…
Pharma is obsessed with dominating
Companies that live in such a zero-sum world don’t “earn market share” from a competitor, they “conquer the market.” They don’t just serve their customers, they “capture” them and they…
While CPG brands move digital in-house, pharma continues to rely on agencies
91% of brands have moved at least a part of their digital marketing operations in-house. (Source: Search Engine Journal) Cost efficiency, greater control, and increased transparency are amongst the biggest reasons…